Wordt geladen...
Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens
The recent development in immune checkpoint inhibitors and chimeric antigen receptor (CAR) T‐cells in the treatment of cancer has not only demonstrated the potency of utilizing T‐cell reactivity for cancer therapy, but has also highlighted the need for developing new approaches to discover targets s...
Bewaard in:
| Gepubliceerd in: | Proteomics |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6032843/ https://ncbi.nlm.nih.gov/pubmed/29786170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pmic.201700465 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|